Obesity and renovascular disease

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Metabolic Disorders

Background:

• Obesity is a major public health issue linked to cardiovascular events and chronic kidney disease (CKD) progression.
• Renal artery stenosis (RAS) prevalence is increasing globally, particularly in the elderly and those with obesity.
• Obesity exacerbates kidney damage in renovascular disease through microvascular regression and adipocyte-mediated injury.

Purpose of the Study:

• To explore the detrimental effects of obesity on kidney damage in the context of renovascular disease.
• To identify potential therapeutic targets for mitigating obesity-induced kidney injury.

Main Methods:

• Review of existing literature on obesity, renovascular disease, and kidney damage.
• Analysis of pathways linking obesity to kidney pathology, including microvascular changes and inflammation.
• Evaluation of current and potential therapeutic interventions.

Main Results:

• Obesity aggravates kidney damage in renovascular disease by worsening microvascular regression and promoting inflammation.
• Adipocytes and insulin resistance play key roles in obesity-induced renal cell injury.
• Dietary modification and renin-angiotensin-aldosterone system inhibition show potential in alleviating obesity-related kidney injury.

Conclusions:

• Obesity significantly worsens structural and functional kidney outcomes in renovascular disease.
• Further research into novel therapeutic interventions targeting obesity-activated pathways is crucial for kidney protection.